#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Progressive supranuclear palsy Leiomyosarcoma recurrent Biotinidase deficiency Liposarcoma Extra-osseous Ewing's sarcoma Tuberous sclerosis complex Thrombotic microangiopathy Squamous cell carcinoma of the vulva Choroidal dystrophy Burkitt's lymphoma Nephroblastoma Dermatomyositis Desmoplastic small round cell tumour Usher's syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Treatment Familial amyotrophic lateral sclerosis – Basic Information Friedreich’s ataxia – Basic Information Phenylketonuria – Diagnostics Nephrotic syndrome – Diagnostics Phenylketonuria Toxic epidermal necrolysis – Trials in Disease Chordoma – Life with Disease Angiosarcoma metastatic – Treatment Splenic marginal zone lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AB521 Vigabatrin Salbutamol Sulfate Ph. Eur. Quinapril Hydrochloride Rmc-6291 Busulfan BNT327 Pal1-15 Acetate Ieramilimab Dobutamine Hydrochloride Ilofotase Alfa Gallium (68Ga) Psma-R2 Cd7-Cart01 Zelicapavir Odm-111 Agomelatine Beclometasone Dipropionate VTX2735 SODIUM 68Ga-Dpi-4452 Romiplostim More therapies…

    Learn about Your Condition

    Albright's disease Pain Pruritus Laryngeal leukoplakia Infection Phenylketonuria Arteriovenous malformation Immune system disorder Alagille syndrome Glomerulonephritis Hyperchylomicronaemia Head injury Chronic hepatitis C Fallopian tube cancer stage IV End stage renal disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • Calcium Folinate
    • Capecitabine
    Germany

  • Study of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    Investigated Drugs:
    • Tarlatamab
    • Temozolomide
    France

  • Study of encorafenib and cetuximab treatment for patients with BRAF V600E-mutant metastatic colorectal cancer who previously responded to BRAF inhibitor therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Encorafenib
    Spain

  • Study of pembrolizumab and lenvatinib treatment for patients with vulvar cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Italy

  • Study comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Remibrutinib
    • Ocrelizumab
    Belgium Czechia Denmark France Germany Greece +4

  • Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Vedolizumab
    Belgium Bulgaria Denmark Ireland Italy The Netherlands +4
Previous Page
1 … 133 134 135 136 137 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!